Skip to main navigation Skip to search Skip to main content

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial

  • ACTT-4 Study Group

Research output: Contribution to journal › Article › peer-review

104   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science